NCT Number: NCT02995200
Quantification of Upper Extremity Use and Effects of Feedback in the Home Setting
A pilot study, the purpose of which is to use accelerometers to quantify UE use (1 and two hand use) in healthy controls and people post-stroke from which the investigators will develop use-based feedback to improve recovery in the home setting. The objectives of this pilot study are to:
i.) determine the feasibility of using accelerometers to quantify amount of UE use in the home setting in healthy individuals and individuals chronic post-stroke,
ii.) quantify and compare the unilateral activity of the weaker (paretic) versus stronger (non-paretic) UEs,
iii.) quantify and compare amount of UE use in healthy controls to that of people chronic post-stroke (side matched unimanual use for each arm and bilateral use) in the home, and
iv.) assess the effect of a few sessions of in-home accelerometer used-based feedback on unilateral and bilateral UE use.
v.) assess kinematic, kinetic, and EMG data during UE movements bilaterally and between healthy controls and subjects post-chronic stroke pre and post feedback (for the people after stroke).
Looking for future studies?
Notify MeKey information
Age range
40 year–100 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy Adults: 40-100 years old, able to follow 2-step commands, able to comply with experimental protocol, living in a home setting, full active range of motion (AROM) in both shoulders and elbows for their age group.
- Individuals Post-stroke: Able to follow 2-step commands, 40 - 100 years old, community dwelling with or without assistance, no upper extremity (UE) injury within the last 3 months, at least 30 degrees of flexion AROM (with or without assistance) and PROM in shoulder and elbow in or out of synergy, intact superficial light touch sensation in both UEs, and at least 6 months post ischemic or hemorrhagic stroke that is either cortical, subcortical or in the cerebellum. It does not need to be their first and only stroke.
Exclusion criteria
- Healthy Adults: Injury of either UE within the last 3 months and unable to follow commands related to the accelerometer use/protocol.
- Individuals Post-stroke: Unable to follow 2 step commands, inability to adhere to study requirements, any neurological diagnosis other than stroke (i.e. Parkinson's Disease, Multiple Sclerosis, etc.), and aphasia limiting their ability to complete the MoCA and Stroke Impact Scale (SIS) questions.
Treatment and study plan
Primary outcomes
-
Amount of Use (measured by accelerometer)
Time frame: 3 week period
Sponsors and collaborators
Lead sponsor
Cleveland State University
Other
Registry information
Acronym: UnSumRes2015
Important dates
- Study start
- 2015
- Primary completion
- 2015
- Study completion
- 2016
- First posted
- Dec 16, 2016
- Registry last updated
- Sep 26, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Core Endurance, Finger Grip Strength, Fatigue, and Hand Function in Patients With Rheumatoid Arthritis
NCT07360496
Arthritis, Arthritis, Rheumatoid
Sivas, Turkey (Türkiye)
View Trial DetailsSerum Trace Element Levels in Some Gynecological Diseases
NCT07210918
Endometrial Cancer, Endometrial Neoplasms
Sivas, Centre, Turkey (Türkiye)
View Trial DetailsTrunk Restraint in Multiple Sclerosis
NCT06982833
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Zonguldak, Turkey (Türkiye)
View Trial DetailsWearable Sensor to Monitor COVID-19 Like Signs and Symptoms
NCT04393558
COVID-19, Coronaviridae Infections
Chicago, Illinois, United States
View Trial Details